Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Supplementary Figure S1 from ARID1A Loss plus CD8+ T-Cell Infiltration Associate with Favorable Clinical Outcomes in Urothelial Carcinoma
Home
Publications
Supplementary Figure S1 from ARID1A Loss plus CD8+ T-Cell Infiltration Associate with Favorable Clinical Outcomes in Urothelial Carcinoma
Supplementary Figure S1 from ARID1A Loss plus CD8+ T-Cell Infiltration Associate with Favorable Clinical Outcomes in Urothelial Carcinoma
Authors:
ZL
Zhaopei Liu
Zhaopei Liu
LZ
Lingkai Zhang
Lingkai Zhang
KJ
Kaifeng Jin
Kaifeng Jin
HZ
Han Zeng
Han Zeng
XS
Xiaohe Su
Xiaohe Su
YD
Yawei Ding
Yawei Ding
JS
Jiaxing Sun
Jiaxing Sun
YW
Yuzhen Wu
Yuzhen Wu
HL
Hailong Liu
Hailong Liu
YZ
Yu Zhu
Yu Zhu
LX
Le Xu
Le Xu
WZ
Weijuan Zhang
Weijuan Zhang
See more
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Download PDF
Download
Open Access
Publisher website
Google Scholar
15 October 2025
other
Published by
American Association for Cancer Research (AACR)
DOI:
10.1158/1078-0432.30363436
Abstract
Enrollment, clinicopathological features and inclusion criteria for ZSHS, FUSCC, and Shanghai-sequencing cohorts.
Keywords
BIOMARKERS
PROGNOSTIC BIOMARKERS
EPIGENETICS
HISTONE MODIFICATION
GENITOURINARY CANCERS
BLADDER CANCER
IMMUNOLOGY
T CELL EXHAUSTION
IMMUNOTHERAPY
BIOMARKERS FOR IMMUNOTHERAPY
CHECKPOINT BLOCKADE
TUMOR MICROENVIRONMENT
IMMUNE CELLS AND THE MICROENVIRONMENT
Related articles
Scroll to top